BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 483386)

  • 1. Evaluation of a new long-acting oxytetracycline formulation against anaplasmosis in colombian cattle.
    Todorovic RA; Gonzalez EF; Garcia O
    Tropenmed Parasitol; 1979 Jun; 30(2):236-8. PubMed ID: 483386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a short and a long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves.
    Stewart CG; Immelman A; Grimbeek P; Grib D
    J S Afr Vet Assoc; 1979 Jun; 50(2):83-5. PubMed ID: 551196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves.
    Kuttler KL; Simpson JE
    Am J Vet Res; 1978 Feb; 39(2):347-9. PubMed ID: 629473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an experimental long-acting oxytetracycline (Terramycin/LA) in the treatment of acute anaplasmosis.
    Kuttler KL; Young MF; Simpson JE
    Vet Med Small Anim Clin; 1978 Feb; 73(2):187-92. PubMed ID: 245908
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle.
    Coetzee JF; Apley MD; Kocan KM
    Vet Ther; 2006; 7(4):347-60. PubMed ID: 17216590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic alterations of Anaplasma marginale in calves after treatment with oxytetracycline.
    Simpson CF
    Am J Vet Res; 1975 Oct; 36(10):1443-6. PubMed ID: 1190584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL
    Res Vet Sci; 1972 Nov; 13(6):536-9. PubMed ID: 4648995
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures.
    Coetzee JF; Apley MD; Kocan KM; Jones DE
    J Vet Pharmacol Ther; 2006 Jun; 29(3):173-83. PubMed ID: 16669861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy to eliminate Anaplasma marginale under field and laboratory conditions.
    Kuttler KL; Johnson LW; Simpson JE
    Proc Annu Meet U S Anim Health Assoc; 1980; 84():73-82. PubMed ID: 6947300
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of long-acting oxytetracycline and imidocarb dipropionate for the chemosterilization of Anaplasma marginale in experimentally infected carrier cattle in Argentina.
    Sarli M; Novoa MB; Mazzucco MN; Morel N; Primo ME; de Echaide ST; Echaide IE
    Vet Parasitol Reg Stud Reports; 2021 Jan; 23():100513. PubMed ID: 33678368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three oxytetracycline regimes for the treatment of persistent Anaplasma marginale infections in beef cattle.
    Coetzee JF; Apley MD; Kocan KM; Rurangirwa FR; Van Donkersgoed J
    Vet Parasitol; 2005 Jan; 127(1):61-73. PubMed ID: 15675047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a long-acting injectable oxytetracycline.
    Cornwell RL
    Mod Vet Pract; 1980 Nov; 61(11):945-7. PubMed ID: 7464772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.